June 2011
Pharmaceutical Representative;Jun2011, Vol. 41 Issue 6, p10
The article offers updates on pharmaceutical studies in the U.S. Outcomes of the two Phase III studies revealed that Onbrez Breezehaler produced improvement to lung function in patients with chronic obstructive pulmonary disease (COPD). Pearl Therapeutics Inc. demonstrated the effectiveness of the Phase IIb study of PT003 to COPD patients. Meritage Pharma Inc.'s clinical trial on oral budesonide suspension (OBS) showed development in patients with eosinophilic esophagitis.


Related Articles

  • DNA Vaccines: An Evolving Approach to the Treatment of Allergic Disorders. Broide, David H. // Allergy & Asthma Proceedings;May/Jun2005, Vol. 26 Issue 3, p195 

    Immunotherapy with protein allergens is effective in modulating the immune response and reducing symptoms in patients with allergic rhinitis and asthma. Unfortunately, the dose of allergen that can be administered to allergic asthmatic patients, who might most benefit from this form of therapy,...

  • Survey of respiratory sounds in infants. Elphick, H. E.; Sherlock, P.; Foxall, G.; Simpson, F. J.; Shiell, N. A.; Primhak, R. A.; Everard, M. L. // Archives of Disease in Childhood;Jan2001, Vol. 84 Issue 1, p35 

    Background-Over the last decade there has been an apparent increase in childhood wheeze. We speculated that much of the reported increase may be attributed to the term wheeze being adopted by parents to describe a variety of other forms of noisy breathing. Aims-To investigate terminology used by...

  • Acute Effects of Aerosolized Iloprost in COPD Related Pulmonary Hypertension - A Randomized Controlled Crossover Trial. Boeck, Lucas; Tamm, Michael; Grendelmeier, Peter; Stolz, Daiana // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Background: Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension (PH). Objectives: To evaluate acute effects of aerosolized iloprost in patients with COPD-associated PH. Methods: A...

  • Effect of tiotropium on quality of life in COPD: a systematic review. Kaplan, Alan // Primary Care Respiratory Journal;Dec2010, Vol. 19 Issue 4, p315 

    Background: Chronic obstructive pulmonary disease (COPD) greatly affects quality of life (QoL). Although QoL is a key concern for the patient, primary endpoints in most clinical trials are objective measures of disease progression. Methods: A systematic review of double-blind randomised...

  • Recruitment barriers in a randomized controlled trial from the physicians' perspective -- A postal survey. Spaar, Anne; Frey, Martin; Turk, Alexander; Karrer, Werner; Puhan, Milo A. // BMC Medical Research Methodology;2009, Vol. 9, Special section p1 

    Background: The feasibility of randomized trials often depends on successful patient recruitment. Although numerous recruitment barriers have been identified it is unclear which of them complicate recruitment most. Also, most surveys have focused on the patients' perspective of recruitment...

  • CLINIC ROUNDUP.  // BioWorld Today;1/8/2010, Vol. 21 Issue 5, p5 

    This section offers news briefs on clinical trials. The ACCORD Phase III trial of Almirall SA and Forest Laboratories Inc. has revealed positive findings regarding aclidinium bromide for the treatment of chronic obstructive pulmonary disease (COPD). RDEA594, the lead candidate to treat...

  • THE NATURAL HISTORY OF IPF IN PATIENTS ELIGIBLE FOR CLINICAL TRIALS VS PATIENTS NOT ELIGIBLE. Macfarlane, P.; Hoo, Z. H.; Hammersley, R. L. S.; McErlean, C. M.; Anpalakhan, S.; Stewart, G. A.; Wallace, W. A.; Murchison, J. T.; Simpson, A. J.; Hirani, N. // Thorax;Dec2011 Supplement, pA63 

    Recruitment to clinical trials is a key objective in the management of IPF. For phase 3 trials, the inclusion and exclusion criteria are stringent. It is not known if the natural history of IPF in patients eligible for clinical trials differs from that in non-eligible patients. Aims To determine...

  • Menthol cigarettes and health risks in Lung Health Study data. Murray, Robert P.; Connett, John E.; Skeans, Melissa A.; Tashkin, Donald P. // Nicotine & Tobacco Research;Jan2007, Vol. 9 Issue 1, p101 

    Whether menthol cigarettes confer a higher risk of death than plain cigarettes is not known. The Lung Health Study (LHS) enrolled 5,887 adult smokers in a clinical trial of smoking cessation and ipratropium in the prevention of chronic obstructive pulmonary disease. LHS participants have been...

  • Clinic Roundup.  // BioWorld Today;8/14/2012, Vol. 23 Issue 157, p5 

    This section offers news briefs on clinical trials, including the commencement of a Phase III trial of oral budesonide suspension for eosinophilic esophagitis from Meritage Pharma Inc.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics